carmoterol (CHF 4226)

DRUG2 trials

Sponsors

Chiesi Farmaceutici S.p.A.

Conditions

Chronic Obstructive Pulmonary Disease

Phase 2

Dose Finding Study of CHF 4226 for Treating Patients With COPD

CompletedNCT00605891

Chiesi Farmaceutici S.p.A.Chronic Obstructive Pulmonary Disease

Start: 2006-10-31End: 2007-06-30Updated: 2017-04-11

Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPD

CompletedNCT00640484

Chiesi Farmaceutici S.p.A.Chronic Obstructive Pulmonary Disease

Start: 2008-04-30End: 2008-10-31Updated: 2010-08-27